SoftOmics is an emerging spin-off from BSC, IRB, and ICREA, focused on delivering scalable software solutions that optimize R&D processes within the Biotech, Life Sciences, Medical, and Pharmaceutical industries. Its flagship product, SamPlexer, is a category-defining software platform for computational sample multiplexing in Next-Generation Sequencing (NGS). SamPlexer streamlines the sequencing library preparation process, making it significantly cheaper, faster, and more sustainable—ultimately driving cost efficiency, accelerating innovation across the R&D lifecycle, and enhancing sequencing-based medical decision-making.
Overview
Solutions
- Software platform
- SamPlexer
Team
-
Hrant Hovhannisyan
CEO -
Toni Gabaldón
CSO -
Arnau Sánchez
Lead Software Engineer